Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | AGXT | P21549 | 2/20 | 0.39 |
| ▸ | F10 | P00742 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 3/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4612615 | 1.00 | CA2 (0.41) | CA2TRPV6NPSR1GLAIDO1 | |
| SCHEMBL1195175 | 1.00 | CA2 (0.41) | CA2TRPV6NPSR1GLAIDO1 | |
| SCHEMBL13269812 | 0.86 | L3MBTL1 (0.40) | CA2NPSR1GLAIDO1AGXT | |
| SCHEMBL26510718 | 0.86 | CA2 (0.43) | CA2NPSR1AGXTF10PKM | |
| SCHEMBL7968239 | 0.84 | CA2 (0.46) | CA2NPSR1F10ALDH1A1TMEM97 | |
| SCHEMBL7968245 | 0.84 | CA2 (0.46) | CA2NPSR1F10ALDH1A1TMEM97 | |
| SCHEMBL17434412 | 0.84 | CA2 (0.42) | CA2NPSR1IDO1F10APP | |
| SCHEMBL5606199 | 0.84 | TMEM97 (0.48) | CA2NPSR1F10L3MBTL1ALDH1A1 | |
| SCHEMBL2182755 | 0.84 | TMEM97 (0.48) | CA2NPSR1F10L3MBTL1ALDH1A1 | |
| SCHEMBL565818 | 0.84 | TMEM97 (0.48) | CA2NPSR1F10L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4321524-B1 | LIPID AND COMPOSITION | SOGO PHARM (JP) | 2025-12-10 | — | — | EP | disclosed |
| EP-4635939-A1 | NOVEL LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION COMPRISING SAME | Korea Institute of Science and Technology (KR) | 2025-10-22 | — | — | EP | disclosed |
| US-20240226287-A1 | NOVEL LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION COMPRISING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240226287-A1 | NOVEL LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION COMPRISING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240226287-A1 | NOVEL LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION COMPRISING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2024-07-11 | — | — | US | disclosed |
| WO-2024128525-A1 | NOVEL LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION COMPRISING SAME | 한국과학기술연구원 | 2024-06-20 | — | — | WO | disclosed |
| US-20240148664-A1 | LIPID AND COMPOSITION | SOGO PHARMACEUTICAL CO., LTD. (JP) | 2024-05-09 | — | — | US | disclosed |
| EP-4321524-A1 | LIPID AND COMPOSITION | Sogo Pharmaceutical Co., Ltd. (JP) | 2024-02-14 | — | — | EP | disclosed |
| CN-117500819-A | Lipid and composition | 相互药工株式会社 | 2024-02-02 | — | — | CN | disclosed |
| WO-2022215758-A1 | LIPID AND COMPOSITION | 相互薬工株式会社 | 2022-10-13 | — | — | WO | disclosed |
| WO-2021038573-A1 | DRUG CONTAINING TARGETING LIPOSOMES | NEXTAR CHEMPHARMA SOLUTIONS LTD. (IL) | 2021-03-04 | — | — | WO | disclosed |
| US-7887835-B2 | for vascular lesion imaging and for diagnosing arteriosclerosis, ischemia with X-ray angiography and positron emission tomography; fluorinated steroid ester, glyceride compounds, phosphatidylcholine, and phosphatidylserine as membrane components of liposome | FUJIFILM CORPORATION (JP) | 2011-02-15 | — | — | US | disclosed |
| EP-1492776-B1 | IODINATED TRIGLYCERIDE ANALOGS | FUJIFILM CORP (JP) | 2008-10-29 | — | — | EP | disclosed |
| US-20080138285-A1 | Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound | FUJIFILM CORPORATION (JP) | 2008-06-12 | — | — | US | disclosed |
| US-7371877-B2 | Glycerol ester derivative | FUJIFILM CORPORATION (JP) | 2008-05-13 | — | — | US | disclosed |
| EP-1916255-A2 | Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound | FUJIFILM Corporation (JP) | 2008-04-30 | — | — | EP | disclosed |
| US-20060062726-A1 | with iodophenyl group (radioisotope), as a membrane component of liposomes, which enables lesion-selective contrast X-ray radiography of a vascular disease; metabolized in the liver, not accumulated in living bodies | FUJIFILM CORPORATION (JP) | 2006-03-23 | — | — | US | disclosed |
| EP-1492776-A2 | IODINATED TRIGLYCERIDE ANALOGS | Fuji Photo Film Co. Ltd. (JP) | 2005-01-05 | — | — | EP | disclosed |
| WO-2003080554-A2 | IODINATED TRIGLYCERIDE ANALOGS | FUJI PHOTO FILM CO., LTD. (JP) | 2003-10-02 | — | — | WO | disclosed |
| US-6274715-B1 | SEMISYNTHETIC MACROLIDES, USEFUL IN BACTERIAL INFECTIONS TREATMENT AND PREVENTION, HAS LESS POTENTIAL FOR DEVELOPING RESISTANCE, IMPROVED OR MODIFIED PROFILES OF DESIRED GRAM-NEGATIVE ACTIVITY | ABBOTT LABORATORIES | 2001-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240148664-A1 | LIPID AND COMPOSITION | PLIN3, PLIN1, FABP1 | CA2 3102/4885TRPV6 3815/4885NPSR1 1609/4885 |
| US-20080138285-A1 | Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound | PHOSPHO1, SGMS1, SGMS2 | CA2 3022/4885TRPV6 670/4885NPSR1 1937/4885 |
| US-20060062726-A1 | with iodophenyl group (radioisotope), as a membrane component of liposomes, which enables lesion-selective contrast X-ray radiography of a vascular disease; metabolized in the liver, not accumulated in living bodies | MSR1, LIPA, LIPC | CA2 1088/4885TRPV6 1641/4885NPSR1 1373/4885 |
| US-20240226287-A1 | NOVEL LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION COMPRISING THE SAME | HDLBP, LRAT, CETP | CA2 4384/4885TRPV6 2254/4885NPSR1 4074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.